JPH0346471B2 - - Google Patents

Info

Publication number
JPH0346471B2
JPH0346471B2 JP59027989A JP2798984A JPH0346471B2 JP H0346471 B2 JPH0346471 B2 JP H0346471B2 JP 59027989 A JP59027989 A JP 59027989A JP 2798984 A JP2798984 A JP 2798984A JP H0346471 B2 JPH0346471 B2 JP H0346471B2
Authority
JP
Japan
Prior art keywords
compound
compounds
formula
activity
rats
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59027989A
Other languages
English (en)
Japanese (ja)
Other versions
JPS59155382A (ja
Inventor
Pufuefurii Pauru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPS59155382A publication Critical patent/JPS59155382A/ja
Publication of JPH0346471B2 publication Critical patent/JPH0346471B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP59027989A 1983-02-16 1984-02-15 麦角アルカロイド誘導体 Granted JPS59155382A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH862/83A CH652719A5 (en) 1983-02-16 1983-02-16 Ergoline derivatives, their preparation and use
CH863/83 1983-02-16
CH862/83 1983-02-16

Publications (2)

Publication Number Publication Date
JPS59155382A JPS59155382A (ja) 1984-09-04
JPH0346471B2 true JPH0346471B2 (enrdf_load_stackoverflow) 1991-07-16

Family

ID=4196915

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59027989A Granted JPS59155382A (ja) 1983-02-16 1984-02-15 麦角アルカロイド誘導体

Country Status (3)

Country Link
JP (1) JPS59155382A (enrdf_load_stackoverflow)
CH (1) CH652719A5 (enrdf_load_stackoverflow)
ZA (1) ZA841150B (enrdf_load_stackoverflow)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2656344A1 (de) * 1975-12-23 1977-07-07 Sandoz Ag Ergolinderivate, ihre verwendung und herstellung

Also Published As

Publication number Publication date
JPS59155382A (ja) 1984-09-04
ZA841150B (en) 1985-09-25
CH652719A5 (en) 1985-11-29

Similar Documents

Publication Publication Date Title
US4877620A (en) Ibuprofen-containing medicament
EP0867179B1 (en) Composition of L-DOPA esters
JP2009537565A (ja) Ｒ（＋）およびｓ（−）プラミペキソール組成とそれを利用する方法
JPH06102623B2 (ja) 中枢神経興奮剤
US6310085B1 (en) Method for the treatment of neurological or neuropsychiatric disorders
CZ282085B6 (cs) Organické soli N,N'-diacetylcystinu
AU782492B2 (en) Method for the treatment of neurological or neuropsychiatric disorders
US4330558A (en) Pharmaceutical composition and method for treating peripheral orthostatic hypotension
EP0317269B1 (en) Antiparkinson ergoline derivatives
RU2213560C2 (ru) Фармацевтическая композиция, содержащая сочетание правовращающего и левовращающего изомеров соталола
US3557292A (en) Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine
EP0207011B1 (en) Use of some alkanoyl l-carnitines for the manufacture of a medicament for therapeutical treatment of idiopathic and induced parkinsonism
US5519057A (en) Ibuprofen-containing medicament
EP0391971A1 (en) IMPROVED TOXICITY CURVES IN CHEMOTHERAPY.
JPH0346471B2 (enrdf_load_stackoverflow)
US3155584A (en) Compositions and method of inhibiting monoamine oxidase and treating hypertension
US3362879A (en) Tyrosine tranquilizing compositions and methods of treatment
US4863962A (en) D-DOPA, pharmaceutically acceptable salts thereof, and methods of treating Parkinson's disease
US3701829A (en) Treatment of parkinson's disease
EP0132880B1 (en) Pharmaceutical compositions containing epinine or a pharmaceutically acceptable salt thereof
US4855325A (en) Treatment of mammals suffering from damage to the central nervous system
NZ258591A (en) Use of idazoxan and derivatives thereof in a medicament for treating parkinsons disease
JPH09500375A (ja) パーキンソン病の治療を目的とする医薬品の製造のためのエファロキサンおよびその誘導体の使用
US4791116A (en) N,N-diethyl-N'-[(8α)-1-ethyl-6-methyl-ergolin-8-yl]-sulfamide useful as prolactin secretion inhibitor, anti-parkinson agents and anti-depressant agents
JP3865450B2 (ja) パーキンソニズム治療剤